Log in to save to my catalogue

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection...

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_904492281

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

About this item

Full title

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2011-08, Vol.378 (9790), p.507-514

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Evidence from Europe, Asia, and North America suggests that standard three-drug regimens of a proton-pump inhibitor plus amoxicillin and clarithromycin are significantly less effective for eradication of Helicobacter pylori infection than are 5-day concomitant and 10-day sequential four-drug regimens that include a nitroimidazole...

Alternative Titles

Full title

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_904492281

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_904492281

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(11)60825-8

How to access this item